Lipitor / Torcetrapib - Combination Therapy for the Management of Dyslipidaemia
Pfizer is exploring the potential to combine its top selling statin Lipitor (atorvastatin) with its investigational compound CP-529,414 for the treatment of dyslipidaemia.
